Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Deep sequencing of HPV E6/E7 genes reveals loss of genotypic diversity and gain of clonal dominance in high-grade intraepithelial lesions of the cervix.

Shen-Gunther J, Wang Y, Lai Z, Poage GM, Perez L, Huang TH.

BMC Genomics. 2017 Mar 14;18(1):231. doi: 10.1186/s12864-017-3612-y.

2.

Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.

Shen-Gunther J, Wang CM, Poage GM, Lin CL, Perez L, Banks NA, Huang TH.

Clin Epigenetics. 2016 Sep 13;8:96. doi: 10.1186/s13148-016-0263-9. eCollection 2016.

3.

Analysis of phosphatases in ER-negative breast cancers identifies DUSP4 as a critical regulator of growth and invasion.

Mazumdar A, Poage GM, Shepherd J, Tsimelzon A, Hartman ZC, Den Hollander P, Hill J, Zhang Y, Chang J, Hilsenbeck SG, Fuqua S, Kent Osborne C, Mills GB, Brown PH.

Breast Cancer Res Treat. 2016 Aug;158(3):441-54. doi: 10.1007/s10549-016-3892-y. Epub 2016 Jul 8.

4.

Death-associated protein kinase 1 promotes growth of p53-mutant cancers.

Zhao J, Zhao D, Poage GM, Mazumdar A, Zhang Y, Hill JL, Hartman ZC, Savage MI, Mills GB, Brown PH.

J Clin Invest. 2015 Jul 1;125(7):2707-20. doi: 10.1172/JCI70805. Epub 2015 Jun 15.

5.

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer.

Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, Savage MI, Osborne CK, Hilsenbeck SG, Chang JC, Mills GB, Lau CC, Brown PH.

Clin Cancer Res. 2015 Apr 1;21(7):1688-98. doi: 10.1158/1078-0432.CCR-14-0432. Epub 2014 Sep 10.

6.

Revealing targeted therapeutic opportunities in triple-negative breast cancers: a new strategy.

Poage GM, Hartman ZC, Brown PH.

Cell Cycle. 2013 Sep 1;12(17):2705-6. doi: 10.4161/cc.25871. Epub 2013 Jul 30. No abstract available.

7.

Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8.

Hartman ZC, Poage GM, den Hollander P, Tsimelzon A, Hill J, Panupinthu N, Zhang Y, Mazumdar A, Hilsenbeck SG, Mills GB, Brown PH.

Cancer Res. 2013 Jun 1;73(11):3470-80. doi: 10.1158/0008-5472.CAN-12-4524-T. Epub 2013 Apr 30.

8.

Identification of an epigenetic profile classifier that is associated with survival in head and neck cancer.

Poage GM, Butler RA, Houseman EA, McClean MD, Nelson HH, Christensen BC, Marsit CJ, Kelsey KT.

Cancer Res. 2012 Jun 1;72(11):2728-37. doi: 10.1158/0008-5472.CAN-11-4121-T. Epub 2012 Apr 16.

9.

In utero exposures, infant growth, and DNA methylation of repetitive elements and developmentally related genes in human placenta.

Wilhelm-Benartzi CS, Houseman EA, Maccani MA, Poage GM, Koestler DC, Langevin SM, Gagne LA, Banister CE, Padbury JF, Marsit CJ.

Environ Health Perspect. 2012 Feb;120(2):296-302. doi: 10.1289/ehp.1103927. Epub 2011 Oct 17.

10.

Global hypomethylation identifies Loci targeted for hypermethylation in head and neck cancer.

Poage GM, Houseman EA, Christensen BC, Butler RA, Avissar-Whiting M, McClean MD, Waterboer T, Pawlita M, Marsit CJ, Kelsey KT.

Clin Cancer Res. 2011 Jun 1;17(11):3579-89. doi: 10.1158/1078-0432.CCR-11-0044. Epub 2011 Apr 19.

11.

Integrated profiling reveals a global correlation between epigenetic and genetic alterations in mesothelioma.

Christensen BC, Houseman EA, Poage GM, Godleski JJ, Bueno R, Sugarbaker DJ, Wiencke JK, Nelson HH, Marsit CJ, Kelsey KT.

Cancer Res. 2010 Jul 15;70(14):5686-94. doi: 10.1158/0008-5472.CAN-10-0190. Epub 2010 Jun 29.

12.

Genetic and epigenetic somatic alterations in head and neck squamous cell carcinomas are globally coordinated but not locally targeted.

Poage GM, Christensen BC, Houseman EA, McClean MD, Wiencke JK, Posner MR, Clark JR, Nelson HH, Marsit CJ, Kelsey KT.

PLoS One. 2010 Mar 11;5(3):e9651. doi: 10.1371/journal.pone.0009651.

Supplemental Content

Loading ...
Support Center